Glen Stevens is a Neurology physician affiliated with Cleveland Clinic. OpenAlex indexes 210 publications with 4,532 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
Sponsor: Case Comprehensive Cancer Center
- Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
Sponsor: Case Comprehensive Cancer Center
- Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Sponsor: Ali Altunkaya
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
44.8%Other antiepileptics31.2%Levetiracetam80%Topiramate20%Part D<11 patientsMood Stabilizer7.8%Lamotrigine100%Part D<11 patients+ 1 more class in this area
Sensory organs
28.1%Corticosteroid28.1%Dexamethasone100%Part D≥42 patientsMetabolism & gastrointestinal
27.1%H2 blocker27.1%Famotidine100%Part D≥42 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2005 per NIH RePORTER. The latest:
- 5-Lipoxygenase inhibition as an adjuvant glioma therapy
Cleveland Clinic Lerner Col/med-Cwru
FY2005$191,539R21CA107277
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”